gms | German Medical Science

17. Jahreskongress für Klinische Pharmakologie

Verbund Klinische Pharmakologie in Deutschland

01. - 02. Oktober 2015, Köln

Multi-step evaluation of data on the multi-target effect of STW 5

Oral Abstract

  • Gerhard Lorkowski - GL Pharma Consulting R & D, Gauting, Germany
  • corresponding author Olaf Kelber - Wissenschaftliche Abteilung, Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany
  • author Heba Abdel-Aziz - Wissenschaftliche Abteilung, Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany
  • author Samuel N. Okpanyi - Wissenschaftliche Abteilung, Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany
  • author Martin Storr - Ludwig Maximilians Universität München, München, and Zentrum für Endoskopie, Starnberg, München, Starnberg, Germany
  • author presenting/speaker Karen Nieber - Pharmakologie, Pharmazeutisches Institut, Universität Leipzig, Leipzig, Germany

17. Jahreskongress für Klinische Pharmakologie. Köln, 01.-02.10.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. Doc15vklipha45

doi: 10.3205/15vklipha45, urn:nbn:de:0183-15vklipha457

Published: September 24, 2015

© 2015 Lorkowski et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

A multitude of concomitant causes and likewise also targets for therapeutic interventions have been identified in functional gastrointestinal diseases (FGDs) [1]. Therefore, a multi-target approach is a promising therapeutic strategy, as is exemplified by the herbal combination medicinal product STW 5, which has been proven to be effective in a large number of clinical studies [2]. Likewise, a large number of studies on the mechanisms of action has been performed.

To allow an overview of these more than 100 nonclinical studies on STW 5 alone, or on STW 5 and its components, were retrieved and studies, study methods and numeric results transferred into a data base. In a second step, study results were sorted according to types of study models and respective etiologic mechanisms related to FGDs and visualized by means of 2D histograms.

The evaluation of the data shows that STW 5 is active in response to multiple etiologic factors involved in functional dyspepsia and irritable bowel syndrome, like hyper- and hypomotility, acidity, inflammation and hypersensitivity, but also in inflammatory gastrointestinal diseases. The clustering by multiple steps allows the conclusion that all components are, with a respective specific profile of activities, involved in these actions, with the 2D histograms allowing an overview of the highly complex body of data within one figure.


References

1.
Allescher, et al. Phytomedicine. 2006;13 SV:2
2.
Ottillinger, et al. WMW. 2013;163:65